At the preparatory meeting, An Ayue stated that at present, chronic diseases have become a major public health problem that seriously endangers the health and social and economic development of Chinese residents. Colorectal and anal diseases have a high incidence, a wide range of patients, and the course of the disease is prolonged and continues to harm. The health of people has caused a great social and economic burden. According to statistics, the total incidence of anorectal diseases among Chinese residents is about 60%. The incidence of hemorrhoids is the highest, accounting for 87.25% of the total number of cases. Colorectal cancer ranks third in the incidence of malignant tumors. However, the prevention and control of colorectal and anal diseases have not attracted enough attention. The purpose of our preparations for the establishment of a professional committee for the prevention and control of colorectal and anal diseases is to give full play to professional expertise, mobilize more medical workers, and vigorously carry out disease prevention and control work. Experts at the conference all agreed and are willing to contribute to the prevention and control of colorectal diseases. The preparatory meeting also made it clear that the inaugural meeting of the Colorectal and Anal Disease Prevention and Control Professional Committee of the Chinese Preventive Medicine Association will be held in the first half of 2016.
On the 28th, three experts An Ayue, Wei Bo, and Dong Ping gave wonderful special reports at the sub-forum on the prevention and control of colorectal diseases. More than 200 medical workers from all over the country and some colleagues in Beijing participated in the sub-forum. The atmosphere at the scene was lively, and the participating experts exchanged enthusiastically, and provided a lot of valuable opinions for the prevention and control of colorectal diseases.
It is reported that Shaobei injection, a new national second-class drug for the treatment of hemorrhoids invented by An Ayue, will be launched on the market. This drug is different from the previous sclerosing agents and necrotic agents. The compound Chinese medicinal preparations purified by advanced technology, and after more than 20 years of clinical verification, have definite curative effect, clinical safety and reliability, short course of treatment, low cost, no complications and sequelae. The launch of the drug will play a more active role in the prevention and control of anorectal diseases.